Emilie Allard-Vannier

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 16

Top Topics

Quality Control

Iron Oxide Nanoparticles

Epidermal Growth Factor Receptor

Endoplasmic Reticulum Stress

Top Venues

Pharmaceuticals (Basel, Switzerland)

Bioconjugate chemistry

Biomacromolecules

This page only lists publications with an associated author ORCID identifier.

Publications

Phuoc-Vinh Nguyen, Emilie Allard-Vannier, Nicolas Aubrey, Christine Labrugère-Sarroste, Igor Chourpa, Julien Sobilo, Alain Le Pape, Katel Hervé-Aubert
Radiolabeling, Quality Control and In Vivo Imaging of Multimodal Targeted Nanomedicines. Pharmaceutics 14 (12) (2022)
Phuoc-Vinh Nguyen, Emilie Allard-Vannier, Nicolas Aubrey, Christine Labrugère-Sarroste, Igor Chourpa, Julien Sobilo, Alain Le Pape, Katel Hervé-Aubert
Radiolabeling, Quality Control and In Vivo Imaging of Multimodal Targeted Nanomedicines. Pharmaceutics 14 (12) (2022)
Phuoc-Vinh Nguyen, Emilie Allard-Vannier, Nicolas Aubrey, Christine Labrugère-Sarroste, Igor Chourpa, Julien Sobilo, Alain Le Pape, Katel Hervé-Aubert
Radiolabeling, Quality Control and In Vivo Imaging of Multimodal Targeted Nanomedicines. Pharmaceutics 14 (12) (2022)
Louis Jolivet, Imène Ait Mohamed Amar, Catherine Horiot, Fanny Boursin, Cyril Colas, Stéphanie Letast, Caroline Denevault-Sabourin, Emilie Allard-Vannier, Nicolas Joubert, Nicolas Aubrey
Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment-Drug Conjugates (FDCs). Pharmaceutics 14 (8) (2022)
Sahar Eljack, Stephanie David, Igor Chourpa, Areeg Faggad, Emilie Allard-Vannier
Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Sahar Eljack, Stephanie David, Igor Chourpa, Areeg Faggad, Emilie Allard-Vannier
Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Sahar Eljack, Emilie Allard-Vannier, Yoann Misericordia, Katel Hervé-Aubert, Nicolas Aubrey, Igor Chourpa, Areeg Faggad, Stephanie David
Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for Efficient Anti-Cancer Activity in HER2+ Breast Cancer Cells. Pharmaceutics 14 (11) (2022)
Phuoc-Vinh Nguyen, Emilie Allard-Vannier, Nicolas Aubrey, Christine Labrugère-Sarroste, Igor Chourpa, Julien Sobilo, Alain Le Pape, Katel Hervé-Aubert
Radiolabeling, Quality Control and In Vivo Imaging of Multimodal Targeted Nanomedicines. Pharmaceutics 14 (12) (2022)
Sahar Eljack, Stephanie David, Igor Chourpa, Areeg Faggad, Emilie Allard-Vannier
Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Sahar Eljack, Stephanie David, Igor Chourpa, Areeg Faggad, Emilie Allard-Vannier
Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Sahar Eljack, Stephanie David, Igor Chourpa, Areeg Faggad, Emilie Allard-Vannier
Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Phuoc-Vinh Nguyen, Emilie Allard-Vannier, Nicolas Aubrey, Christine Labrugère-Sarroste, Igor Chourpa, Julien Sobilo, Alain Le Pape, Katel Hervé-Aubert
Radiolabeling, Quality Control and In Vivo Imaging of Multimodal Targeted Nanomedicines. Pharmaceutics 14 (12) (2022)
Sanaa Ben Djemaa, Katel Hervé-Aubert, Laurie Lajoie, Annarita Falanga, Stefania Galdiero, Steven Nedellec, Martin Soucé, Emilie Munnier, Igor Chourpa, Stéphanie David, Emilie Allard-Vannier
gH625 Cell-Penetrating Peptide Promotes the Endosomal Escape of Nanovectorized siRNA in a Triple-Negative Breast Cancer Cell Line. Biomacromolecules 20 (8) (2019)
Katel Hervé-Aubert, Emilie Allard-Vannier, Nicolas Joubert, Zineb Lakhrif, Christophe Alric, Camille Martin, Marie-Claude Viaud-Massuard, Isabelle Dimier-Poisson, Nicolas Aubrey, Igor Chourpa
Impact of Site-Specific Conjugation of ScFv to Multifunctional Nanomedicines Using Second Generation Maleimide. Bioconjugate chemistry 29 (5) (2018)
Christophe Alric, Katel Hervé-Aubert, Nicolas Aubrey, Souad Melouk, Laurie Lajoie, William Même, Sandra Même, Yann Courbebaisse, Anastasia A Ignatova, Alexey V Feofanov, Igor Chourpa, Emilie Allard-Vannier
Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes. Journal of nanobiotechnology 16 (1) (2018)
Nicolas Aubrey, Emilie Allard-Vannier, Camille Martin, Francesca Bryden, Stéphanie Letast, Cyril Colas, Zineb Lakhrif, Nils Collinet, Isabelle Dimier-Poisson, Igor Chourpa, Marie-Claude Viaud-Massuard, Nicolas Joubert
Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro. Bioconjugate chemistry 29 (11) (2018)